HeadInvest LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,703
Closed -$996K 212
2025
Q1
$996K Sell
14,703
-9,325
-39% -$558K 0.19% 98
2024
Q4
$1.08M Sell
24,028
-2,750
-10% -$154K 0.2% 87
2024
Q3
$1.68M Sell
26,778
-5,994
-18% -$350K 0.31% 70
2024
Q2
$1.94M Sell
32,772
-5,690
-15% -$356K 0.38% 64
2024
Q1
$3.07M Sell
38,462
-2,119
-5% -$162K 0.6% 46
2023
Q4
$3.2M Sell
40,581
-3,213
-7% -$229K 0.67% 43
2023
Q3
$3.05M Sell
43,794
-1,962
-4% -$139K 0.66% 42
2023
Q2
$3.43M Sell
45,756
-15,947
-26% -$1.13M 0.74% 40
2023
Q1
$4.59M Sell
61,703
-2,734
-4% -$229K 1.01% 33
2022
Q4
$6M Buy
64,437
+526
+0.8% +$50.8K 1.34% 25
2022
Q3
$6.09M Buy
63,911
+712
+1% +$70.5K 1.46% 21
2022
Q2
$5.86M Buy
63,199
+92
+0.1% +$8.98K 1.3% 22
2022
Q1
$6.39M Buy
63,107
+55
+0.1% +$5.78K 1.22% 25
2021
Q4
$6.5M Buy
63,052
+1,553
+3% +$144K 1.15% 25
2021
Q3
$5.22M Buy
61,499
+450
+0.7% +$37.7K 0.99% 35
2021
Q2
$5.09M Buy
61,049
+510
+0.8% +$41.8K 0.97% 36
2021
Q1
$4.55M Sell
60,539
-835
-1% -$60.8K 0.93% 37
2020
Q4
$4.19M Buy
61,374
+1,602
+3% +$104K 0.89% 38
2020
Q3
$3.49M Buy
59,772
+1,035
+2% +$64.4K 1.01% 34
2020
Q2
$3.82M Buy
58,737
+4,635
+9% +$292K 1.2% 32
2020
Q1
$3.21M Buy
54,102
+47,699
+745% +$3.18M 1.2% 31
2019
Q4
$476K Buy
6,403
+692
+12% +$48.6K 0.14% 113
2019
Q3
$360K Buy
5,711
+1,004
+21% +$59.5K 0.11% 124
2019
Q2
$256K Buy
4,707
+450
+11% +$24.2K 0.07% 155
2019
Q1
$230K Buy
+4,257
New +$263K 0.06% 170
2018
Q4
Sell
-3,032
Closed -$239K 183
2018
Q3
$239K Buy
+3,032
New +$217K 0.07% 158
2016
Q3
Sell
-2,664
Closed -$255K 134
2016
Q2
$255K Hold
2,664
0.1% 113
2016
Q1
$276K Hold
2,664
0.11% 110
2015
Q4
$260K Buy
2,664
+250
+10% +$24.5K 0.11% 110
2015
Q3
$233K Hold
2,414
0.09% 111
2015
Q2
$253K Buy
2,414
+100
+4% +$10.2K 0.09% 108
2015
Q1
$239K Hold
2,314
0.09% 105
2014
Q4
$223K Buy
+2,314
New +$204K 0.09% 98

Other funds holding CVS

HeadInvest LLC's CVS Position: Q2 2025 in Review

HeadInvest LLC sold out of CVS Health (CVS) in Q2 2025, closing a stake of 14,703 shares — an estimated $996K sold.

HeadInvest LLC first reported a position in CVS in Q4 2014 and held it in 33 quarters. The position peaked at $6.5M in Q4 2021. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • HeadInvest LLC reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • HeadInvest LLC sold 14,703 CVS Health shares in Q2 2025, an estimated $996K.
  • HeadInvest LLC first reported a position in CVS Health in Q4 2014 and held it in 33 quarters.
  • HeadInvest LLC's CVS Health position peaked at $6.5M in Q4 2021.
  • 1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on HeadInvest LLC's 13F filing for Q2 2025, filed 14 Aug 2025.